Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
INIS
enzymes
100%
diseases
75%
therapy
56%
humans
51%
proteins
51%
production
46%
storage
44%
sulfates
42%
mutations
36%
patients
31%
accumulation
30%
genes
29%
gene therapy
29%
vectors
28%
bones
22%
metabolism
22%
fibroblasts
22%
yeasts
20%
in vitro
19%
substrates
17%
mice
17%
colombia
17%
biology
17%
design
17%
central nervous system
15%
ph value
15%
lysosomes
15%
stability
13%
tools
13%
reviews
13%
delivery
13%
evaluation
12%
transport
12%
brain
12%
reduction
12%
errors
11%
stem cells
11%
concentration
11%
drugs
10%
modeling
10%
lipids
10%
interactions
10%
enzyme activity
10%
assessments
10%
bioreactors
10%
oxidation
10%
oxygen
10%
chondroitin
10%
glycoproteins
9%
applications
9%
strains
9%
viruses
8%
bovine
8%
levels
8%
in vivo
8%
tissues
7%
genetics
7%
nanoparticles
7%
kinetics
6%
host
6%
cartilage
6%
microorganisms
6%
laboratories
6%
mitochondria
6%
nervous system diseases
6%
construction
6%
prediction
6%
vaccines
6%
molecules
6%
damage
6%
information
5%
matrices
5%
escherichia coli
5%
screening
5%
range
5%
myelin
5%
yields
5%
neurons
5%
oligosaccharides
5%
pathogenesis
5%
comparative evaluations
5%
transcription factors
5%
management
5%
lactobacillus
5%
peptides
5%
chimeras
5%
drug delivery
5%
gangliosides
5%
amino acids
5%
catabolism
5%
Biochemistry, Genetics and Molecular Biology
Mucopolysaccharidosis
50%
Enzyme
47%
Genome Editing
26%
Sulfatase
18%
Komagataella pastoris
18%
Deficiency
17%
Glycosaminoglycan
16%
Fibroblast
16%
Lysosomal Storage Disease
15%
Iduronate-2-Sulfatase
15%
Sulfate
14%
Hexosaminidase
14%
CRISPR
13%
N-Acetylgalactosamine
12%
Gene Therapy
12%
GM2 Gangliosidoses
12%
Lysosome
11%
Pharmacological Chaperone
10%
Recombinant
9%
Methylotrophic Yeast
9%
Arylsulfatase A
8%
Reconstruction
8%
Keratan Sulfate
7%
Escherichia coli
6%
Non-Viral Vector
6%
Hematopoietic Stem Cell Transplantation
6%
Chondroitin
5%
Hunter Syndrome
5%
CRISPR/Cas9
5%
Tay-Sachs Disease
5%
Metachromatic Leukodystrophy
5%
Keyphrases
MPS IVA
17%
Lysosomal Storage Disease
15%
Pharmacological Chaperone
14%
Photosystem II
13%
Genome Editing
12%
GALNS
11%
Recombinant
10%
Gene Therapy
9%
Enzyme Replacement Therapy
9%
Lysosomal Enzymes
6%
N-acetylgalactosamine-6-sulfate Sulfatase
5%
Therapeutic Potential
5%
Pichia Pastoris
5%